Pediatrix Medical Group, Inc. (NYSE:MD) EVP Mary Ann E. Moore Sells 8,108 Shares

Pediatrix Medical Group, Inc. (NYSE:MD) EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $16.00, for a total transaction of $129,728.00. Following the completion of the transaction, the executive vice president now owns 135,810 shares in the company, valued at approximately $2,172,960. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Pediatrix Medical Group Stock Down 1.8 %

Pediatrix Medical Group stock opened at $15.22 on Thursday. The firm’s 50 day moving average price is $12.38 and its two-hundred day moving average price is $9.77. The firm has a market cap of $1.31 billion, a PE ratio of -4.97, a P/E/G ratio of 2.22 and a beta of 1.55. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $16.41. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. Pediatrix Medical Group’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.29 earnings per share. On average, research analysts predict that Pediatrix Medical Group, Inc. will post 1.25 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on MD shares. UBS Group increased their price target on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Mizuho upped their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, Truist Financial increased their target price on Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $16.10.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently made changes to their positions in MD. nVerses Capital LLC bought a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at approximately $31,000. Innealta Capital LLC acquired a new stake in Pediatrix Medical Group in the second quarter valued at approximately $33,000. Quest Partners LLC grew its position in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares in the last quarter. Nisa Investment Advisors LLC grew its position in Pediatrix Medical Group by 47.2% in the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after acquiring an additional 1,524 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Pediatrix Medical Group during the 2nd quarter worth $72,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.